While the numbers of coronaviruses around the world are alarmingly increasing, and about one billion people are subject to compulsory isolation in their homes, good news comes from the vaccine and treatment of the emerging virus from Germany and France.

Franz Werner Haas, the acting German head of the German company, Corvac, said that tens of thousands of people infected with corona could get a vaccine for the virus this fall.

He added that after “the progress made by the company’s scientists, the clinical trials for this vaccine will be launched next summer.”

“If the German authorities agree, we will start production,” Hass said, adding that his company has a production capacity of between 200 and 400 million doses of vaccine for the Corona virus in one year.

The director of the Al-Jazeera office in Germany, Issa Al-Tibi, said that Haass also confirmed that the German vaccination of the virus will be the best in the world.

Al-Tibi added that the largest shareholder of the German company, Corvac, said in a new press interview that his company had received a lot of support from the European Union, and that as a result it could prove to humankind its ability to produce millions of doses of the vaccine to the world.

Promising experiences in France
French Professor Didier Raoul, director of the University Hospital Institute in Marseille, revealed, during a clinical trial, the effectiveness of the drug hydroxychloroquine used to treat malaria in the recovery of people infected with the Coronavir virus (Covid-19).

The French study revealed by Raoul showed that all people with corona were cured after being treated for six consecutive days with hydroxychloroquine and azithromycin together.

The study said that the treatment of hydroxychloroquine prevents the reproduction of the virus in the human body, and works to reduce and disappear viral infections in patients “Covid-19”.

She added that the effect of this drug is enhanced by azithromycin, which accelerates the recovery of patients.

During a television interview, French Professor Didier Raoul called for more experiments on this drug, which he said might contribute to controlling the spread of Corona.

Al-Jazeera correspondent in France said that Raul confirmed that three quarters of those who underwent treatment with this drug recovered, and that those who refused to use it remained ill.

The director of health in the French Ministry of Health was quoted as saying that the French authorities welcome these studies and research, and that they asked a specialized body in the ministry to scrutinize them more.

A French government spokeswoman was also quoted as saying that France welcomes all studies, and pointed out that she nevertheless seemed conservative when she said that there is still no scientific information in order to adopt such a protocol.

He added that doctors and other researchers have also reserved the study, and they stressed that it is necessary to know the repercussions that may be left by the use of the drug to the injured, especially if the patient is forced to take many doses.

Meanwhile, Stanford University medical advisor Gregory Regano said that a study conducted in France by the brightest doctors specializing in infectious diseases confirmed the effectiveness of the drug hydroxychloroquine, which is used to treat malaria in treating corona. In an interview with Fox News, Reagano confirmed that the cure rate of those who underwent trials was 100%.

For his part, US President Donald Trump said in a new tweet that there is a real opportunity for the drugs “hydro-cycloroquine” and “azetromycin” to bring about the most significant transformation in the history of medicine.

6 Russian vaccines
And in Moscow, Russian Prime Minister Mikhail Michaustin announced that his country’s scientists are currently testing 6 vaccines against the Corona virus “Covid-19”.

“We hope that its effectiveness (vaccines) will be confirmed soon,” according to Channel Russia yesterday.

“Six drugs of this type are currently being tested in Russia, and our scientists have developed them in a very short time, in just two months, through the use of available innovations and the latest in biotechnology,” he added.

The Federal Authority for Consumer Rights Monitoring in Russia said Friday that Russian scientists have begun testing prototypes for possible vaccines for the Corona virus on animals in a laboratory in Siberia, adding that scientists expect to start launching a vaccine in the last three months of 2020.

Russia’s Victor Center for Virology and Biotechnology stated that it has developed vaccine models based on six different technological concepts, and they began testing on Monday.

As for the director of the Russian Influenza Research Institute of the Russian Ministry of Health, Dmitry Liuznov, he said that the production of a vaccine for Koruna may take from one and a half years to 3 years, explaining that the fastest process in this series is the idea of ​​preparing the vaccine, and then a long process begins for studies on the clinical cases of animals, Then the actual research will be on healthy volunteers.

An experimental treatment in America
For its part, the American “NBC” channel reported that an experimental treatment for Corona virus using an anti-viral drug showed clear signs of improvement for at least two patients in the United States within 24 hours.

The channel added that the experimental treatment that was previously used to treat injured people in Wuhan, China, is believed to prevent corona from multiplying inside the body.

And medical sources in the United States confirmed that the drug, produced by an American company, has officially entered the stage of clinical trials for about one thousand patients in the country, and the results will appear by the end of next April.

On the other hand, the drug manufacturer announced that up to this point it has not been proven safe for treatment with Corona, and has not issued approval from any party for its use of the drug, as the company confirmed that it supports five clinical trials around the world to study the safety and effectiveness of the drug.

In parallel with these developments, the Chinese mainland has not recorded for the third consecutive day new cases of coronavirus at the local level, while the number of infections detected by arrivals from abroad increased.

Source: Al-Jazeera + agencies

Leave a Reply